www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

LL-37/CAP-18, Human, mAb 1-1C12

Catalogue number:
HM2071-20UG
Supplier:
Size:
20 µg _$$_
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£132.00 Shipping is calculated in checkout
Applications:

Immuno assays, Immuno fluorescence, Paraffin sections, Western blot

Immunogen:

mixture of synthetic native and glutaraldehyde cross-linked LL-37<sup>1sup>

Product Description:

The monoclonal antibody 1-1C12 recognizes free LL-37 as well as its precursor human CAP18 (hCAP18). hCAP18 is a cathelicidin protein of ~18 kDa. It belongs to the cathelicidin family of antimicrobial peptides that are characterised by a conserved N-terminal cathelin domain and a variable C-terminal antimicrobial domain. Cathelicidins are predominantly found in the peroxidase-negative granules of neutrophils. During bacterial infections, the life span of neutrophils is regulated by various pathogen- and host-derived substances. Within the neutrophils, the cathelicidins are synthesised as preproproteins. After removal of the signal peptide,they are stored in granules as inactive proforms. The C-terminal antimicrobial peptides are activated when cleaved from the proforms of the cathelicidins by serine proteases from azurophil granules.hCAP18 is a major protein in specific granules of neutrophils, but it is also present in subpopulations of lymphocytes and monocytes, in squamous epithelia (of the mouth, tongue, esophagus, cervix, and vagina), pulmonary epithelium, keratinocytes in inflammatory skin diseases and in the epididymus. The antibacterial C-terminus of hCAP18, LL-37 (37 amino acids), has been shown to exert broad antimicrobial activity towards gram-negative as well as gram-positive bacteria and to have synergistic antibacterial effects with the defensins. For instance deficiency in saliva, LL-37 accords with occurrence of periodontal disease in patients with morbus Kostmann. LL-37 does not only kill bacteria, but can also modulate (suppress) neutrophil apoptosis via the activation of FPRL1 and P2X7 in bacterial infections. Suppression of neutrophil apoptosis results in the prolongation of their life span, and may be advantageous for host defense against bacterial invasion. Moreover it functions as a chemotactic agent for neutrophils, monocytes and T cells. LL-37 is markedly resistant to proteolytic degradation and to a limited extent also cytotoxic towards mammalian cells.

HM2071-20UG LL-37/CAP-18, Human, mAb 1-1
HM2071-20UG LL-37/CAP-18, Human, mAb 1-1C12
Details Cat number & supplier Size Price
LL-37/CAP-18, Human, mAb 3D11 HM2070-20UG · Hycult Biotech
HM2070-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
C3/C3b, Human, mAb 755 HM2072-20UG · Hycult Biotech
HM2072-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
C3/C3a, Human, mAb 474 HM2073-20UG · Hycult Biotech
HM2073-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
TLR4, Human, mAb HTA125 HM2068-20UG · Hycult Biotech
HM2068-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
C3a/C3a des Arg, Human, mAb 2991 HM2074-20UG · Hycult Biotech
HM2074-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
C3/C3a, Human, mAb 2898 HM2075-20UG · Hycult Biotech
HM2075-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
TLR2, Human, mAb TL2.3 HM2066-20UG · Hycult Biotech
HM2066-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
C5/C5a, Human, mAb 561 HM2076-20UG · Hycult Biotech
HM2076-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
C5/C5a, Human, mAb 557 HM2077-20UG · Hycult Biotech
HM2077-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
TLR2, Human, mAb TL2.1 HM2064-20UG · Hycult Biotech
HM2064-20UG
Hycult Biotech
20 µg £132.00
20 µg
view